“In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison give a recap of their experience at the Meet Delic conference in Las Vegas. Meet Delic is an annual conference for psychedelic wellness and business industry professionals. “
“The continued growth in the acceptance of medical trials of psychedelic substances has created a unique opportunity for growth of Delic Holdings Corp.”
“As a result of the transaction, Delic now operates 13 ketamine infusion centers in the U.S, making it the largest network of psychedelic wellness clinics in the country.”
“Lamar Odom spoke about his journey to beat addiction through the use of psychedelic medicines at Meet Delic: The World’s Premiere Psychedelic and Wellness Edutainment Event and Expo over the weekend of November 6 and 7 in Las Vegas.”
“In this op-ed, Dr. Roggen et al. propose a system for websites like Leafly that would allow its users to share revenue from their content and personal data, enabling a higher sense of trust, credibility and ultimately more value for every stakeholder involved.”
“The end-product must be tested for a proper result, and according to Dr. Markus Roggen, the President and CSO of Delic Labs, the end-product for a vape pen is the vapor.”
“The former NBA athlete will take the stage at AREA15 in Las Vegas, Nevada, on Nov. 7 to host a discussion about his healing journey with psychedelic medicine and preview his documentary, Lamar Odom Reborn, with director Zappy Zapolin.”
“There is a great deal of incredible research. You have NYU, Johns Hopkins, Imperial College of London, all setting up centers of excellence around psychedelics and psychedelic medicine because these substances are perhaps the greatest breakthrough in mental wellness in the last 100 years.”
“Recent studies are showing encouraging results. A 2019 report published in the Indian Journal of Psychiatry found male participants with severe depression had significant improvement in their illness after receiving a six-dose regimen of intravenous ketamine.”
“These novel molecules are perhaps the most beneficial way to help people with mental health disorders. Right now Canada has the only licensure that allows for psilocybin research.”
